{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:01:44Z","timestamp":1792123304764,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier","isbn-type":[{"value":"9780323950572","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["DK126452"],"award-info":[{"award-number":["DK126452"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-0011"],"award-info":[{"award-number":["I-0011"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL139793"],"award-info":[{"award-number":["HL139793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1034300"],"award-info":[{"award-number":["PO1034300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.apha.2023.01.002","type":"book-chapter","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T10:48:02Z","timestamp":1677235682000},"page":"229-255","source":"Crossref","is-referenced-by-count":29,"title":["20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apha.2023.01.002_bb0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/HJH.0000000000003038","article-title":"Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase","volume":"40","author":"Agostinucci","year":"2022","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf8683","article-title":"Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity","volume":"373","author":"Akbari","year":"2021","journal-title":"Science"},{"key":"10.1016\/bs.apha.2023.01.002_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.HYP.29.1.320","article-title":"Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide","volume":"29","author":"Alonso-Galicia","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200547","article-title":"Targeted metabolomic approach in men with carotid plaque","volume":"13","author":"Auguet","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.002_bb0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.121.001036","article-title":"Neutrophil-derived myeloperoxidase and hypochlorous acid critically contribute to 20-Hydroxyeicosatetraenoic acid increases that drive postischemic angiogenesis","volume":"381","author":"Azcona","year":"2022","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0035","first-page":"294","article-title":"20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways","volume":"57","author":"Bao","year":"2011","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0040","article-title":"Epoxyeicosatrienoic acid analog and 20-HETE antagonist combination prevent hypertension development in spontaneously hypertensive rats","volume":"12","author":"Baranowska","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0045","doi-asserted-by":"crossref","first-page":"31709","DOI":"10.1074\/jbc.M304437200","article-title":"20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells","volume":"278","author":"Basora","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0050","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0055","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.STR.0000065829.45234.69","article-title":"Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage","volume":"34","author":"Cambj-Sapunar","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2023.01.002_bb0060","first-page":"2020","article-title":"GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells","volume":"158573","author":"Cardenas","year":"1865","journal-title":"Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids"},{"key":"10.1016\/bs.apha.2023.01.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111784","article-title":"20-HETE\/GPR75 pairing modulates the expression and transcriptional activity of the androgen receptor in androgen-sensitive prostate cancer cells","volume":"559","author":"Cardenas","year":"2023","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.prostaglandins.2011.12.005","article-title":"20-HETE in neovascularization","volume":"98","author":"Chen","year":"2012","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9440(10)62282-1","article-title":"Inhibitors of cytochrome P450 4A suppress angiogenic responses","volume":"166","author":"Chen","year":"2005","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0080","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.113.210120","article-title":"20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo","volume":"348","author":"Chen","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2016.04.002","article-title":"20-HETE contributes to ischemia-induced angiogenesis","volume":"83","author":"Chen","year":"2016","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0090","doi-asserted-by":"crossref","first-page":"H1468","DOI":"10.1152\/ajpheart.00690.2018","article-title":"CYP4A\/20-HETE regulates ischemia-induced neovascularization via its actions on endothelial progenitor and preexisting endothelial cells","volume":"316","author":"Chen","year":"2019","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0095","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-21-4029","article-title":"CYP4F2-catalyzed metabolism of arachidonic acid promotes stromal cell-mediated immunosuppression in non-small cell lung Cancer","volume":"82","author":"Chen","year":"2022","journal-title":"Cancer Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0100","doi-asserted-by":"crossref","first-page":"H1018","DOI":"10.1152\/ajpheart.01172.2007","article-title":"20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling","volume":"294","author":"Cheng","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0105","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"32","author":"Cheng","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0110","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1096\/fj.13-241927","article-title":"Vascular characterization of mice with endothelial expression of cytochrome P450 4F2","volume":"28","author":"Cheng","year":"2014","journal-title":"FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0115","doi-asserted-by":"crossref","first-page":"F544","DOI":"10.1152\/ajprenal.2000.279.3.F544","article-title":"Angiotensin II releases 20-HETE from rat renal microvessels","volume":"279","author":"Croft","year":"2000","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1742-7843.2009.00501.x","article-title":"A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats","volume":"106","author":"Cuez","year":"2010","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0125","doi-asserted-by":"crossref","first-page":"F753","DOI":"10.1152\/ajprenal.00292.2013","article-title":"20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension","volume":"305","author":"Ding","year":"2013","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99576","article-title":"Human duct cells contribute to beta cell compensation in insulin resistance","volume":"4","author":"Dirice","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/bs.apha.2023.01.002_bb0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2014.08.002","article-title":"Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease","volume":"113-115","author":"Dreisbach","year":"2014","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0140","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCRESAHA.117.311022","article-title":"GPR75 identified as the first 20-HETE receptor: A chemokine receptor adopted by a new family","volume":"120","author":"Fan","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082482","article-title":"20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.002_bb0150","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2741\/4465","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/bs.apha.2023.01.002_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prostaglandins.2012.03.001","article-title":"The functional variant V433M of the CYP4F2 and the metabolic syndrome in swedes","volume":"98","author":"Fava","year":"2012","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1076029611436197","article-title":"A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease","volume":"19","author":"Fu","year":"2013","journal-title":"Clinical and applied thrombosis\/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/bs.apha.2023.01.002_bb0165","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"26","author":"Gangadhariah","year":"2015","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/bs.apha.2023.01.002_bb0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.115.229377","article-title":"20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-kappaB translocation and promoter binding","volume":"356","author":"Garcia","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0175","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.prostaglandins.2014.12.001","article-title":"Androgen-induced hypertension in angiotensinogen deficient mice: Role of 20-HETE and EETS","volume":"116-117","author":"Garcia","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0185","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0190","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1073\/pnas.1918761117","article-title":"Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase","volume":"117","author":"Garcia","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Pt 3","key":"10.1016\/bs.apha.2023.01.002_bb0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1469-7793.1998.771bs.x","article-title":"Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current","volume":"507","author":"Gebremedhin","year":"1998","journal-title":"The Journal of Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0200","doi-asserted-by":"crossref","first-page":"R934","DOI":"10.1152\/ajpregu.00125.2018","article-title":"High-fat diet-induced obesity and insulin resistance in CYP4a14(\u2212\/\u2212) mice is mediated by 20-HETE","volume":"315","author":"Gilani","year":"2018","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0205","first-page":"1245","article-title":"Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel","volume":"37","author":"Gross","year":"2004","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cardiores.2005.06.007","article-title":"Cytochrome P450 and arachidonic acid metabolites: Role in myocardial ischemia\/reperfusion injury revisited","volume":"68","author":"Gross","year":"2005","journal-title":"Cardiovascular Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.106.115360","article-title":"Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation","volume":"321","author":"Guo","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0220","doi-asserted-by":"crossref","first-page":"H602","DOI":"10.1152\/ajpheart.00874.2008","article-title":"20-HETE can act as a nonhypoxic regulator of HIF-1alpha in human microvascular endothelial cells","volume":"297","author":"Guo","year":"2009","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0225","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2022.02.011","article-title":"Activation of 20-HETE synthase triggers oxidative injury and peripheral nerve damage in type 2 diabetic mice","volume":"23","author":"Haddad","year":"2022","journal-title":"The Journal of Pain"},{"key":"10.1016\/bs.apha.2023.01.002_bb0230","first-page":"H2098","article-title":"Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels","volume":"266","author":"Harder","year":"1994","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1582-4934.2006.tb00290.x","article-title":"Arteriogenesis versus angiogenesis: Similarities and differences","volume":"10","author":"Heil","year":"2006","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/bs.apha.2023.01.002_bb0240","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/oxfordjournals.jbchem.a021245","article-title":"Sex and strain differences in constitutive expression of fatty acid omega-hydroxylase (CYP4A-related proteins) in mice","volume":"119","author":"Hiratsuka","year":"1996","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0245","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1073\/pnas.081627898","article-title":"Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension","volume":"98","author":"Holla","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2023.01.002_bb0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prostaglandins.2015.03.002","article-title":"Vascular actions of 20-HETE","volume":"120","author":"Hoopes","year":"2015","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0255","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/bs.apha.2023.01.002_bb0260","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.kint.2022.04.033","article-title":"Caloric restriction reduces the pro-inflammatory eicosanoid 20-hydroxyeicosatetraenoic acid to protect from acute kidney injury","volume":"102","author":"Hoyer-Allo","year":"2022","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2023.01.002_bb0265","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/ATVBAHA.112.301116","article-title":"MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome","volume":"33","author":"Hutcheson","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0270","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.00364.2009","article-title":"Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE","volume":"297","author":"Inoue","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2012.12.002","article-title":"Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia","volume":"100\u2013101","author":"Issan","year":"2013","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0285","doi-asserted-by":"crossref","first-page":"R822","DOI":"10.1152\/ajpregu.2001.280.3.R822","article-title":"Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid","volume":"280","author":"Ito","year":"2001","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0290","doi-asserted-by":"crossref","first-page":"41809","DOI":"10.1038\/srep41809","article-title":"Intravenous formulation of HET0016 decreased human glioblastoma growth and implicated survival benefit in rat xenograft models","volume":"7","author":"Jain","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apha.2023.01.002_bb0295","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/ATVBAHA.116.308344","article-title":"Pharmacological targeting of plasminogen activator Inhibitor-1 decreases vascular smooth muscle cell migration and neointima formation","volume":"36","author":"Ji","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.RES.0000111523.12842.FC","article-title":"Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels","volume":"94","author":"Jiang","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0305","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FJC.0000000000000499","article-title":"beta-adrenergic receptor-stimulated cardiac myocyte apoptosis: Role of cytochrome P450 omega-hydroxylase","volume":"70","author":"Jiang","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0310","doi-asserted-by":"crossref","first-page":"H528","DOI":"10.1152\/ajpheart.00561.2016","article-title":"Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction","volume":"312","author":"Joseph","year":"2017","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0315","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1021\/acs.jmedchem.2c01089","article-title":"Discovery of novel Pyrazolylpyridine derivatives for 20-Hydroxyeicosatetraenoic acid synthase inhibitors with selective CYP4A11\/4F2 inhibition","volume":"65","author":"Kawamura","year":"2022","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0320","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/me.2012-1139","article-title":"20-HETE induces hyperglycemia through the cAMP\/PKA-PhK-GP pathway","volume":"26","author":"Lai","year":"2012","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0325","doi-asserted-by":"crossref","first-page":"H1107","DOI":"10.1152\/ajpheart.00961.2015","article-title":"20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition","volume":"310","author":"Lakhkar","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0330","article-title":"20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.002_bb0335","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ki.2009.67","article-title":"Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure","volume":"75","author":"Liu","year":"2009","journal-title":"Kidney International"},{"key":"10.1016\/bs.apha.2023.01.002_bb0340","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: From discovery to biology","volume":"23","author":"Loos","year":"2022","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0345","doi-asserted-by":"crossref","first-page":"L902","DOI":"10.1152\/ajplung.00278.2007","article-title":"20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells","volume":"294","author":"Medhora","year":"2008","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0350","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1540\/jsmr.41.175","article-title":"Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. Journal of smooth muscle research =","volume":"41","author":"Miyata","year":"2005","journal-title":"Nihon Heikatsukin Gakkai kikanshi"},{"key":"10.1016\/bs.apha.2023.01.002_bb0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","article-title":"HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme","volume":"133","author":"Miyata","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/abio.2001.5044","article-title":"Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs","volume":"292","author":"Nithipatikom","year":"2001","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0365","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","article-title":"Inhibition of cytochrome P450omega-hydroxylase: A novel endogenous cardioprotective pathway","volume":"95","author":"Nithipatikom","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0370","doi-asserted-by":"crossref","first-page":"H500","DOI":"10.1152\/ajpheart.00918.2005","article-title":"Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection","volume":"290","author":"Nithipatikom","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0375","first-page":"5","article-title":"Eicosanoids: Generation and detection in mammalian cells","volume":"462","author":"O'Donnell","year":"2009","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.113.203844","article-title":"20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries","volume":"346","author":"Orozco","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0385","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bjp.0702171","article-title":"Functional response of the rat kidney to inhibition of nitric oxide synthesis: Role of cytochrome p450-derived arachidonate metabolites","volume":"125","author":"Oyekan","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0390","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1074\/jbc.RA117.001297","article-title":"GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells","volume":"293","author":"Park","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0395","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.lfs.2005.03.002","article-title":"Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells","volume":"77","author":"Parmentier","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/bs.apha.2023.01.002_bb0400","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FJC.0000000000001013","article-title":"Unraveling the role of 12- and 20- HETE in cardiac pathophysiology: G-protein-coupled receptors, pharmacological inhibitors, and transgenic approaches","volume":"77","author":"Pascale","year":"2021","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0405","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1111\/bph.15525","article-title":"Uncovering the signalling, structure and function of the 20-HETE-GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75","volume":"178","author":"Pascale","year":"2021","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0410","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.prostaglandins.2016.04.004","article-title":"Oxidized HDL is a potent inducer of adipogenesis and causes activation of the ang-II and 20-HETE systems in human obese females","volume":"123","author":"Peterson","year":"2016","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0415","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/DMSO.S342799","article-title":"Mice lacking Gpr75 are Hypophagic and thin","volume":"15","author":"Powell","year":"2022","journal-title":"Diabetes, metabolic syndrome and obesity : targets and therapy"},{"key":"10.1016\/bs.apha.2023.01.002_bb0420","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.0000047240.33861.6B","article-title":"20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase","volume":"41","author":"Randriamboavonjy","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0425","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function","volume":"192","author":"Rocic","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","article-title":"20-HETE: Hypertension and beyond","volume":"72","author":"Roman","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0435","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2018.09.003","article-title":"Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor","volume":"139","author":"Rong","year":"2018","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0440","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1074\/jbc.M116.732297","article-title":"20-Hydroxyeicosatetraenoic acid (HETE)-dependent hypertension in human cytochrome P450 (CYP) 4A11 transgenic mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR","volume":"291","author":"Savas","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0445","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1016\/S0895-7061(02)03006-6","article-title":"Beyond blood pressure: The endothelium and atherosclerosis progression","volume":"15","author":"Schiffrin","year":"2002","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0450","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171496","article-title":"20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: A study in Cyp1a1-ren-2 transgenic rats","volume":"38","author":"Sedlakova","year":"2018","journal-title":"Bioscience Reports"},{"key":"10.1016\/bs.apha.2023.01.002_bb0455","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.089599","article-title":"Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension","volume":"50","author":"Singh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0460","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2018.02.005","article-title":"Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation","volume":"117","author":"Soler","year":"2018","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0465","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fphar.2015.00261","article-title":"Peroxisome proliferator-activated receptor alpha, PPARalpha, directly regulates transcription of cytochrome P450 CYP2C8","volume":"6","author":"Thomas","year":"2015","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0470","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fendo.2014.00152","article-title":"The G-protein-coupled long-chain fatty acid receptor GPR40 and glucose metabolism","volume":"5","author":"Tomita","year":"2014","journal-title":"Frontiers in Endocrinology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0475","doi-asserted-by":"crossref","first-page":"H1194","DOI":"10.1152\/ajpheart.00733.2010","article-title":"20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1","volume":"300","author":"Tsai","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0480","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-017-02539-4","article-title":"20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1","volume":"9","author":"Tunaru","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2023.01.002_bb0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.niox.2013.05.001","article-title":"Contribution of iNOS\/sGC\/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock","volume":"33","author":"Tunctan","year":"2013","journal-title":"Nitric Oxide : Biology and Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0490","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0000000000001265","article-title":"Activation of GPR75 signaling pathway contributes to the effect of a 20-HETE mimetic, 5,14-HEDGE, to prevent hypotensive and tachycardic responses to lipopolysaccharide in a rat model of septic shock","volume":"80","author":"Tunctan","year":"2022","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0495","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1158\/0008-5472.CAN-22-2774","article-title":"The heat is on: 20-HETE instructs an immunosuppressive phenotype in Cancer-associated fibroblasts","volume":"82","author":"Van Ginderachter","year":"2022","journal-title":"Cancer Research"},{"key":"10.1016\/bs.apha.2023.01.002_bb0500","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11010-011-1035-7","article-title":"Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats","volume":"359","author":"Vasudevan","year":"2012","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0505","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen activator Inhibitor-1 is a marker and a mediator of senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0510","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fphys.2017.00865","article-title":"Improving cardiometabolic health with diet, physical activity, and breaking up sitting: What about sleep?","volume":"8","author":"Vincent","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0515","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/bs.apha.2023.01.002_bb0520","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3389\/fphar.2019.00876","article-title":"Specific inhibition of CYP4A alleviates myocardial oxidative stress and apoptosis induced by advanced glycation end-products","volume":"10","author":"Wang","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.151298","article-title":"Fine particulate matter and vasoactive 20-hydroxyeicosatetraenoic acid: Insights into the mechanisms of the prohypertensive effects of particulate air pollution","volume":"806","author":"Wang","year":"2022","journal-title":"The Science of the Total Environment"},{"key":"10.1016\/bs.apha.2023.01.002_bb0530","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.diabres.2006.04.001","article-title":"20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans","volume":"74","author":"Ward","year":"2006","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/bs.apha.2023.01.002_bb0535","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/HJH.0000000000000208","article-title":"The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss","volume":"32","author":"Ward","year":"2014","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.apha.2023.01.002_bb0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.0000152356.85791.52","article-title":"Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II\/salt-induced aortic remodeling","volume":"25","author":"Weisberg","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0545","doi-asserted-by":"crossref","first-page":"13868","DOI":"10.1074\/jbc.M111.334896","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) is a novel activator of transient receptor potential vanilloid 1 (TRPV1) channel","volume":"287","author":"Wen","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apha.2023.01.002_bb0550","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-hydroxyeicosatetraeonic acid: A new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0555","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathol-020712-163936","article-title":"The influence of innate and adaptive immune responses on atherosclerosis","volume":"9","author":"Witztum","year":"2014","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-HETE and blood pressure regulation: Clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiology in Review"},{"key":"10.1016\/bs.apha.2023.01.002_bb0565","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes","volume":"308","author":"Xu","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2023.01.002_bb0570","article-title":"Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2023.01.002_bb0575","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00067.2010","article-title":"20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes","volume":"299","author":"Zeng","year":"2010","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0580","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FJC.0000000000000248","article-title":"20-Hydroxyeicosatetraenoic acid is a key mediator of angiotensin II-induced apoptosis in cardiac myocytes","volume":"66","author":"Zhao","year":"2015","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/bs.apha.2023.01.002_bb0585","first-page":"2018","article-title":"Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice","volume":"860-870","author":"Zhou","year":"1864","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/bs.apha.2023.01.002_bb0590","first-page":"R228","article-title":"20-HETE is an endogenous inhibitor of the large-conductance ca(2+)-activated K+ channel in renal arterioles","volume":"270","author":"Zou","year":"1996","journal-title":"The American Journal of Physiology"}],"container-title":["Advances in Pharmacology","Bioactive Lipid Mediators in Cardiopulmonary Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358923000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T06:22:36Z","timestamp":1753338156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358923000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780323950572"],"references-count":117,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2023.01.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}